Health and Fitness Health and Fitness
Thu, June 17, 2010
[ 10:42 AM ] - Market Wire
PPD clasificada una de las mejores organizaciones de investigacin por contrato de Europa en 2010
[ 10:41 AM ] - Market Wire
Central Ohio Companies Collaborate to Develop Novel Imaging Technology for Head and Neck Cancers
[ 10:16 AM ] - Market Wire
Medtronic CFO Gary Ellis to Speak at the Wells Fargo Securities Healthcare Conference
[ 09:59 AM ] - Market Wire
Positron Key Points & Developments
[ 06:30 AM ] - Market Wire
New Data Presented At ECFS Conference Highlight P .. vide Benefit to Adolescent Cystic Fibrosis Patien
[ 06:30 AM ] - Market Wire
Horizon Health International Corp. BCSC-Revocation of Cease Trade Order
[ 06:01 AM ] - Market Wire
Medtronic Announces European Launch of Protectaa" .. Technology Shown to Significantly Reduce Inapprop
[ 06:00 AM ] - Market Wire
Allos Therapeutics' Pralatrexate Granted Orphan M .. for the Treatment of Cutaneous T-Cell Lymphoma by
[ 06:00 AM ] - Market Wire
Alnylam Secures Intellectual Property and Technol .. Applications in Vaccine Research and Development
[ 05:35 AM ] - Market Wire
ZIOPHARM Announces 2010 Annual Meeting of Stockholders
[ 05:30 AM ] - Market Wire
Optimum Interactive (USA) Ltd.: Optimum Interacti .. ses Capital Line to $6 Million by Founder & Board
[ 05:00 AM ] - Market Wire
San West Inc. and CountyImports.com Exceed Revenue Guidance
[ 05:00 AM ] - Market Wire
St. Jude Medical Announces First Enrollment in La .. al Trial of Novel Heart Failure Management System
[ 04:33 AM ] - Market Wire
Apax shareholding in Galapagos placed with institutional investors
[ 04:09 AM ] - Market Wire
Mymetics' Phase Ib Malaria Vaccine: Safe, Well To .. Lasting Antibody Response in Children in Tanzania
[ 04:00 AM ] - Market Wire
Eurand Announces Data on Switching Cystic Fibrosi .. reatic Insufficiency From Unapproved PEPs to FDA-
[ 04:00 AM ] - Market Wire
Alnylam Receives Notice of Allowance from United .. ffice for New Patent Broadly Covering RNAi Therap
[ 04:00 AM ] - Market Wire
Bioniche Strengthens its International Patent Por .. r its MCC &; Oligonucleotide Technology Platforms
[ 03:30 AM ] - Market Wire
AngioDynamics to Hold Fiscal 2010 Fourth Quarter .. inancial Results Conference Call on July 15, 2010
[ 01:31 AM ] - Market Wire
Human Genome Sciences and GlaxoSmithKline Announc .. SS-52 Phase 3 SLE Study Results for BENLYSTA® (b
[ 01:30 AM ] - Market Wire
Human Genome Sciences and GlaxoSmithKline Announc .. f BLISS-76 Phase 3 Study Results for BENLYSTA® i
[ 01:00 AM ] - Market Wire
Micrus Endovascular Receives Approval to Market DeltaPaq and DeltaPlush Microcoils in Japan
Wed, June 16, 2010
[ 06:30 PM ] - Market Wire
Law Offices of Howard G. Smith Announces Investig .. Behalf of Shareholders of Somanetics Corporation
[ 06:30 PM ] - Market Wire
Law Offices of Howard G. Smith Announces Investig .. olders of Talecris Biotherapeutics Holdings Corp.
[ 03:22 PM ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Investigation of Amedisys, Inc. 401(k) Plan
[ 02:42 PM ] - Market Wire
KCI erhlt FDA-Zulassung fr das Prevenaa" Incision Management System
[ 02:42 PM ] - Market Wire
KCI krijgt goedkeuring van de FDA voor het Prevena Incision Management System
[ 02:42 PM ] - Market Wire
KCI recibe la autorizacin de la FDA para el Sistema de manejo de incisiones Prevenaa"
[ 02:42 PM ] - Market Wire
KCI recebe liberao da FDA para o sistema Prevenaa" de gesto de incises
[ 01:31 PM ] - Market Wire
Covidien maakt definitieve overeenkomst overname Somanetics Corporation bekend

Covidien maakt definitieve overeenkomst overname Somanetics Corporation bekend


Published on 2010-06-16 13:35:36 - Market Wire
  Print publication without navigation


DUBLIN & TROY, Mich.--([ BUSINESS WIRE ])--Covidien plc (NYSE: COV) en Somanetics Corporation (NASDAQ: SMTS) maken vandaag bekend een definitieve overeenkomst te hebben getekend betreffende de fusie-overeenkomst waarbij Covidien alle uitstaande aandelen van Somanetics Corporation zal opkopen voor 25,00 dollar in contanten per aandeel. Het gaat om een totaalbedrag van 250 miljoen dollar. Deze overname is in lijn met de strategie van Covidien om uit te breiden, bijvoorbeeld op het gebied van marktleidende technologie en verkoopinfrastructuur. Somanetics is een leider op het gebied van cerebrale en somatische oximetrie.

Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal welke als enige juridische geldigheid beoogt.

Contributing Sources